Chemotherapy Treatment in Melbourne
Chemotherapy uses anti-cancer medicines to destroy cancer cells or slow their growth. It remains an important treatment for many solid tumours and blood cancers, but modern chemotherapy is highly individualised: the drugs, dose, schedule and duration depend on the exact diagnosis, stage of disease, treatment goal, other therapies being used and the patient’s general health. Some people receive chemotherapy for a relatively short period around surgery, while others need repeated cycles to control advanced or relapsed disease.
Northern Blood & Cancer Care provides specialist chemotherapy planning and ongoing review for patients across Melbourne. Our medical oncologists and haematologists work with day oncology services at Northern Private Hospital and Northern Health, where intravenous anti-cancer treatments can be delivered when clinically appropriate. The same specialist who recommends treatment remains involved in monitoring response, blood results and side effects, and can coordinate surgery, radiotherapy, supportive care or tertiary referral when these form part of the wider treatment plan.
Chemotherapy is a broad term for medicines that interfere with the way cancer cells grow and divide. Different drugs act at different points in the cell cycle, which is why more than one medicine is sometimes combined in a treatment regimen. Chemotherapy is systemic treatment: medicines given into a vein or taken by mouth can reach cancer cells throughout the body rather than treating only one local area.
The word “chemotherapy” can sound as though every patient receives the same treatment, but regimens vary substantially. A treatment used for breast cancer may be very different from one used for bowel cancer, lymphoma or myeloma. Your specialist will explain the purpose of the recommended regimen, how it is given, how often treatment is repeated and what benefit is expected in your particular situation.
Chemotherapy may be given before an operation to shrink a tumour, treat microscopic cancer cells elsewhere in the body and provide information about how the cancer responds to treatment. This approach is used in selected breast, rectal, upper gastrointestinal and other cancers. The response can sometimes influence the operation or the treatment recommended afterwards.
Chemotherapy remains part of treatment for a number of leukaemias, lymphomas, myeloma and other haematological malignancies, often in combination with antibodies, targeted medicines or other immune-based treatments. Some intensive regimens, stem cell transplantation and cellular therapies require tertiary haematology services; Northern Blood & Cancer Care’s haematologists can coordinate these pathways while maintaining continuity of specialist care.
Many chemotherapy regimens are given through an intravenous cannula or a central venous access device in a day oncology unit. Others include tablets or capsules taken at home. Treatment is usually organised in cycles, with treatment days followed by a recovery period before the next cycle. The interval may be weekly, fortnightly, three-weekly or follow another schedule depending on the regimen.
Before each cycle, the treating team checks that it remains safe to proceed. This commonly includes a clinical review and blood tests to assess white cells, haemoglobin, platelets, kidney function and liver function. Some regimens also require heart monitoring or other baseline and follow-up tests. A delay or dose adjustment is sometimes the safest response to side effects or slow blood-count recovery and does not necessarily mean the treatment is no longer effective.
Side effects vary considerably between drugs. It is therefore more useful to understand the expected effects of your own regimen than to assume that every chemotherapy patient will experience nausea, hair loss or severe fatigue. Modern anti-nausea medicines, growth-factor support and dose adjustments can prevent or reduce many treatment problems.
Common possibilities include fatigue, nausea, appetite or taste changes, constipation or diarrhoea, mouth soreness, lowered blood counts, increased infection risk, bruising, hair thinning or hair loss, and numbness or tingling in the hands and feet. Some medicines can affect the heart, kidneys, hearing, lungs or other organs, which is why treatment-specific monitoring is important. Fertility can also be affected by some chemotherapy, and patients for whom future fertility matters should raise this before treatment begins whenever possible.
A fever or rapidly worsening illness during chemotherapy can represent infection when white-cell counts are low and may require urgent assessment. Patients are given clear instructions about who to contact and which symptoms should not wait until the next appointment. New chest pain, severe breathlessness, uncontrolled vomiting or diarrhoea, significant bleeding, confusion or other severe symptoms should be assessed urgently.
Chemotherapy is only one part of cancer care. The Northern Blood & Cancer Care team considers how treatment fits with surgery, radiotherapy, targeted therapy, immunotherapy, hormone therapy and supportive care. For people with blood cancers, the haematology team also considers transfusion needs, infection prevention, bone-marrow recovery and whether tertiary treatments such as transplantation should form part of the pathway.
Northern Blood & Cancer Care’s specialists have appointments across Northern Health and other major Melbourne cancer services and are involved in multidisciplinary care and clinical research. This allows treatment decisions to be informed by tumour-specific expertise while patients can continue to receive specialist consultation close to home in Melbourne’s north. Northern Private Hospital provides a day chemotherapy service, and Northern Health operates an Oncology and Medical Day Unit for outpatient cancer and haematology treatment.
Supportive care can also be coordinated where relevant. Infectious diseases expertise is available within the practice for complex infections or patients whose immune systems are suppressed, while needs such as lymphoedema management or exercise rehabilitation can be referred to appropriate hospital or external services.
If chemotherapy is being considered, please bring a current referral, medication list and any relevant pathology, imaging, operative or biopsy reports. Details of previous cancer treatment and any significant reactions are also useful. Your specialist will explain the aim of treatment, expected benefit, schedule, likely side effects, alternatives and the monitoring required before you decide whether to proceed.
You are welcome to bring a family member or support person. For a new cancer diagnosis, there can be a large amount of information to absorb, and having another person present can help with questions and remembering the discussion.
Northern Blood & Cancer Care includes medical oncologists and haematologists with experience in immune-based cancer treatment and clinical research. The clinicians most closely associated with this service include:
Chemotherapy decisions depend on much more than the name of a cancer. Northern Blood & Cancer Care combines tumour-specific oncology and haematology expertise with access to day-treatment services, multidisciplinary care and coordinated supportive services, allowing the regimen, monitoring and side-effect plan to be tailored to the individual patient and the goal of treatment.
Northern Blood & Cancer Care brings together a highly experienced team of haematologists, medical oncologists and specialist physicians, with consultations available at Northern Private Hospital in Epping.
Contact our team to arrange an appointment or discuss a referral.
